ACUTE LYMPHOCYTIC LEUKEMIA
Clinical trials for ACUTE LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Boosted stem cells aim to speed recovery in aggressive blood cancers
Disease control OngoingThis study is testing whether specially grown cord blood stem cells can help patients with high-risk blood cancers recover their immune systems faster after a transplant. Participants receive a transplant using these expanded stem cells after strong chemotherapy. Researchers are …
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Targeted attack on hidden leukemia cells after chemo
Disease control OngoingThis study is testing a targeted drug called inotuzumab ozogamicin for adults with a type of acute lymphoblastic leukemia (ALL). It is for patients who have responded to initial chemotherapy but still have very low levels of detectable cancer cells, known as minimal residual dise…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Scientists test 'Booster Pill' to supercharge Cancer-Fighting cells
Disease control OngoingThis study is testing if taking an oral drug called duvelisib after receiving CAR-T cell therapy can help the engineered immune cells survive longer in the body and work better. It will involve about 42 adults with certain types of lymphoma or leukemia who are already scheduled t…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Scientists reprogram Patient's own cells to hunt blood cancer
Disease control OngoingThis is an early-stage safety study testing a new type of treatment for patients whose B-cell lymphoma or leukemia has returned or not responded to standard therapies. Doctors take a patient's own immune cells (T cells), genetically modify them in a lab to better recognize and at…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Frozen donor marrow tested as lifeline for blood cancer patients
Disease control TerminatedThis early-stage trial aimed to test the safety of a new bone marrow transplant method for adults with leukemia and related blood cancers. It planned to use frozen bone marrow tissue from deceased, partially matched donors, combined with specific medications to prevent complicati…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC